Publication | Closed Access

Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis

Translational MedicineRecombinant Human Granulocyte-colonyAmyotrophic Lateral SclerosisGranulocyteMedicineNeurological DisorderLong Term AdministrationImmunologyHematologyNeurologyNeuropathologyNeuroimmunologyCell TransplantationNeuroinflammation